Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer

Fig. 2

Kaplan-Meier curves of patients with initially resectable CRLM grouped by DNA ploidy, stroma fraction and nucleotyping. A Comparison of recurrence-free survival (RFS) between the diploid DNA ploidy group and the nondiploid DNA ploidy group. B Comparison of overall survival (OS) between the diploid DNA ploidy group and the nondiploid DNA ploidy group. C Comparison of RFS between the high stroma fraction group and the low stroma fraction group. D Comparison of OS between the high stroma fraction group and the low stroma fraction group. E Comparison of RFS between the chromatin heterogeneous group and the chromatin homogeneous group. F Comparison of OS between the chromatin heterogeneous group and the chromatin homogeneous group

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us